Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Recombinant, modified adenoviral vectors for tumor specific gene expression and uses thereof

Recombinant, modified adenoviral vectors for tumor specific gene expression and uses thereof

US Patent 6686196 · Granted Feb 3, 2004

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Desmoglein 2 (DSG2) binding proteins and uses therefor2025
Desmoglein 2 (DSG2) binding proteins and uses therefor2023
Desmoglein 2 (DSG2) binding proteins and uses therefor2022
Desmoglein 2 (DSG2) binding proteins and uses therefor2020
Desmoglein 2 (DSG2) binding proteins and uses therefor2018
Desmoglein 2 (DSG2) binding proteins and uses therefor2017
Methods and systems for adenovirus interaction with desmoglein 2 (DSG2)2015
Compositions and methods for modulating the activity of complement regulatory pr2014
Methods and systems for adenovirus interaction with desmoglein 2 (DSG2)2014
Recombinant adenoviral vectors expressing chimeric fiber proteins for cell speci2006
Expression cassette for antisense expression of ribozyme2001
Methods and compositions for enhanced stability of non-adenoviral DNA2000